A wound that won't close. A diabetic foot ulcer that keeps getting infected. A venous leg ulcer that's been there for years. The psychological and physical toll is real - and so is the risk of amputation, scarring, and permanent loss of function.
Written by — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Ulcers that don't progress toward healing despite standard care
local_fire_department
Chronic Inflammation
The wound stays inflamed, preventing progression to the healing phase
warning
Infection Risk
Diabetic ulcers especially vulnerable to bacterial colonization and sepsis
Understanding Wound Healing
Why Some Wounds Get Stuck
Normally, wound healing follows a predictable sequence. Your body signals growth factors like PDGF and EGF, which recruit fibroblasts to lay down new collagen, stimulate angiogenesis (blood vessel formation), and orchestrate epithelialization (new skin growth).
But in chronic wounds—especially diabetic and venous ulcers—this process stalls. High blood glucose damages the nerves that sense injury and the blood vessels that deliver oxygen and nutrients. Venous insufficiency creates a hostile microenvironment with poor drainage and oxygen deprivation. The growth factors get produced, but at insufficient levels or in the wrong timing. Inflammatory cells persist when they should be clearing out. The wound stays stuck in the inflammatory phase.
The result? A ulcer that's open for months or years, vulnerable to infection, and at constant risk of spreading deeper—sometimes ending in amputation.
format_quoteGrowth factors at 20% of normal levels = a wound that essentially gives up trying to heal.
This is where peptide therapy intervenes directly. Becaplermin (FDA-approved) supplies the missing PDGF. Other peptides address the root problems: recruiting immune cells, stimulating blood vessel formation, accelerating collagen deposition, and creating a healing-promoting microenvironment.
check_circle
1997
Becaplermin (Regranex)
The FDA-Approved Foundation
Recombinant platelet-derived growth factor (PDGF) FDA-approved specifically for diabetic foot ulcers. The gold standard growth factor for wound healing.
Its role
Calling in reinforcements that your body isn't producing enough of
Typical range
0.01% topical gel application
The bottom line
Becaplermin is the only FDA-approved topical growth factor for chronic wounds. It directly signals fibroblasts and inflammatory cells to complete the healing cascade that diabetic neuropathy and vascular dysfunction have interrupted.
bolt
1981
Thymosin Beta-4
The Cellular Regeneration Accelerator
A naturally occurring peptide that accelerates tissue repair, increases cell migration, and promotes vascularization—showing dramatic results in wound healing trials.
Its role
Emergency repair squad sent to coordinate cell rebuilding
Typical range
2-5 mg per week
The bottom line
TB-500 is like putting your body's repair crews on overdrive. It signals cells to migrate to the wound, accelerates collagen synthesis, and promotes the formation of new blood vessels—directly addressing the core failures in chronic wounds.
A naturally occurring peptide found in gastric juices that promotes comprehensive tissue repair including blood vessel formation, collagen synthesis, and immune modulation.
Its role
Your gut's healing signal, applied to skin wounds
Typical range
250-500 mcg per dose
The bottom line
BPC-157 works through multiple mechanisms: it increases VEGF and HGF (growth factors that build blood vessels), modulates inflammation to prevent chronic stalling, and directly stimulates fibroblast activity. It's especially valuable for venous ulcers where inflammatory stalling is the primary problem.
Epidermal growth factor applied directly to wounds, driving epithelialization and coordinating the multiple cell types needed for wound closure.
Its role
Telling skin cells 'grow now' with biological authority
Typical range
0.01-0.05% topical formulations
The bottom line
EGF is the primary growth factor for skin epithelial cells. Applied topically, it directly stimulates keratinocytes to migrate and proliferate, accelerating the final stage of wound closure when new skin must cover the healing wound bed.
auto_awesome
1997
GHK-Cu
The Collagen Remodeler
A copper peptide complex that stimulates collagen synthesis, remodels wound tissue, and reduces inflammation—proven in wound healing research.
Its role
Fine-tuning the collagen architecture for strength
Typical range
0.5-3 mg per application
The bottom line
GHK-Cu doesn't just build collagen—it builds organized, well-formed collagen with proper cross-linking for tissue strength. It also modulates inflammation and promotes wound contraction, making it valuable throughout the healing process.
A naturally occurring antimicrobial peptide that kills bacteria, modulates inflammation, and promotes healing—critical for infection-prone diabetic ulcers.
Its role
Antimicrobial defense that also signals healing
Typical range
0.1-1 mg topical or systemic
The bottom line
LL-37 kills bacteria directly but doesn't create antibiotic resistance. It also stimulates immune cells and accelerates wound healing. For diabetic ulcers prone to infection, LL-37 addresses both the infection risk AND the underlying healing dysfunction in a single mechanism.
05auto_awesomeGHK-CuThe Collagen RemodelerFine-tuning the collagen architecture for strength
06shieldLL-37 (Cathelicidin)The Infection FighterAntimicrobial defense that also signals healing
5 angles of attack
check_circle
Growth Factor Signaling
Becaplermin (PDGF), EGF, and TB-500 provide missing growth factor signals, recruiting and activating the fibroblasts and endothelial cells needed for new tissue formation
bolt
Vascular Restoration
BPC-157, TB-500, and EGF all promote angiogenesis through different mechanisms, restoring the blood flow and oxygen delivery that diabetic neuropathy and venous insufficiency have compromised
build
Collagen Architecture
GHK-Cu builds organized collagen with proper cross-linking while other peptides recruit the cells to synthesize it, creating strong tissue rather than scar
shield
Infection Prevention
LL-37 provides antimicrobial activity and immune stimulation while other peptides restore the inflammatory balance, preventing the bacterial colonization that stalls healing
auto_awesome
Comprehensive Restoration
Together these peptides restore the complete wound healing cascade—growth signaling, vascularization, immune coordination, structural tissue formation, and epithelialization
An honest breakdown based on research and clinical reports.
schedule
Phase 1 of 5
Week 1-2
Establishing the Environment
What's happening inside
The peptides are establishing growth factor signaling. Wound bed is being cleaned and prepared. Infection risk is being managed. The basic conditions for healing are being created.
Inflammation may shift (less localized redness, more organized response)
Wound bed quality improves as necrotic tissue is cleared
Increased granulation tissue formation visible
warning Watch for
If infection signs increase despite peptide therapy (increasing drainage, spreading redness, fever), may need additional antimicrobial support or systemic antibiotics. Don't assume peptides will overcome severe ongoing infection alone.
Realistic expectations
The goal here is stabilization—stopping the decline—not yet expecting active healing.
auto_awesome
Phase 2 of 5
Week 3-4
Healing Phase Initiation
What's happening inside
Growth factor signaling is activating fibroblasts and endothelial cells. New blood vessels are beginning to form. Collagen deposition is increasing. The wound is transitioning from inflammatory stalling into productive healing.
What you might notice
Wound bed becomes more pink/red (indicating increased blood flow)
Granulation tissue (bumpy red tissue) becomes more prominent
Wound size may start decreasing
Drainage becomes more serous (clear/yellow) and less purulent
Wound odor improves as infection risk decreases
Surrounding skin shows signs of epithelialization (new pink skin at wound edges)
warning Watch for
This is when some diabetic wounds show dramatic improvement while others progress more slowly. Compliance with daily PDGF application is critical—missing doses will stall progress.
Realistic expectations
You're seeing the first real evidence that the wound is healing rather than deteriorating. The trajectory is changing.
trending_up
Phase 3 of 5
Month 2-3
Accelerating Closure
What's happening inside
New blood vessels have formed substantially. Collagen deposition is creating strong tissue structure. Epithelialization is accelerating at the wound margins. The wound is visibly closing and the healing rate is increasing.
What you might notice
Wound size decreasing noticeably each week (typically 20-30% reduction per week)
Epithelialization advancing from all margins
Wound depth decreasing as base fills in with new tissue
Callus formation around wound edges as pressure tolerance improves
Pain often decreases as granulation tissue matures
You can often see the trajectory toward complete closure
warning Watch for
Pressure relief remains critical. Even with excellent peptide support, continuing pressure on a healing diabetic ulcer will cause it to stall or regress.
Realistic expectations
For most wounds, this is when healing becomes self-evident and encouraging. You're in the productive phase with clear weekly progress.
check_circle
Phase 4 of 5
Month 4-6
Completion and Remodeling
What's happening inside
The wound is either closing or nearly closed. The epithelialization is complete. New collagen is being remodeled into stronger organized tissue. The skin over the healed wound is still vulnerable but structurally closed.
What you might notice
Wound fully epithelialized (closed with new skin)
Skin over wound may still be fragile and somewhat different texture
Surrounding callus is maturing
Pain has resolved
Patient can typically return to normal activity with appropriate footwear/compression
Risk of re-ulceration remains but can be managed with prevention
warning Watch for
Newly healed wounds are vulnerable to re-injury. The new skin is mechanically weaker than original skin for months. Pressure relief and monitoring for any signs of re-ulceration are essential.
Realistic expectations
Most wounds that respond to peptide therapy are closed by this point. Some more aggressive or larger wounds may extend to 8-12 weeks, but the trajectory should be clear by month 3.
auto_awesome
Phase 5 of 5
6+ Months
Prevention and Tissue Maturation
What's happening inside
The new tissue continues to mature and strengthen. Scar tissue remodeling occurs. The healed wound site becomes more durable. Focus shifts to preventing re-ulceration.
What you might notice
Healed wound is fully closed and functional
Tissue strength and durability improve over months
Scar tissue becomes less prominent (collagen remodeling continues for 12+ months)
Patient can engage in normal activities
With proper prevention (footwear, pressure relief, monitoring), re-ulceration risk decreases
warning Watch for
Prevention is everything. Diabetic ulcers recur in 30-40% of cases within one year if prevention measures aren't followed. Venous ulcers recur frequently without compression.
Realistic expectations
You've achieved closure, but sustained prevention is the next challenge.
General guidelines based on research literature and clinical reports. Work with a healthcare provider experienced in peptide therapy to customize for your situation.
warningImportant: These are general guidelines. Don't self-prescribe based on internet articles. Work with a qualified healthcare provider.
Becaplermin (Regranex) · typical range
0.01%
topical gel application
Common protocols
medicationStandard: 0.01% gel applied once daily using provided measurement device (amount depends on ulcer size)
medicationTypical application: 1/2 inch ribbon per square inch of ulcer surface
medicationFrequency: Once daily, reassess every 1-2 weeks
Timing considerations
scheduleApply after wound cleansing and debridement
scheduleAllow to air dry for 12 hours before covering
scheduleKeep wound moist between applications
scheduleConsistent daily application crucial for results
repeat Cycling
Apply once daily until ulcer closes, typically 8-20 weeks
Most reconstituted peptides stable 3-4 weeks refrigerated
Keep away from light in dark bottles
Never freeze reconstituted peptides
Unreconstituted peptides can be stored frozen for extended periods
Check specific instructions for each peptide as storage varies
water_dropReconstitution
Use bacteriostatic water (contains preservative), not sterile water
Calculate volume needed for appropriate dosing concentration
Inject water slowly down the side of the vial, not directly into powder
Swirl gently to mix - never shake vigorously
Wait until fully dissolved before drawing up doses
If reconstituted solution looks cloudy or has particles, discard and start fresh
Peptides work best as part of a comprehensive approach.
monitor_heart
Pressure Relief
The Non-Negotiable Foundation
No peptide in the world will heal a diabetic foot ulcer if you keep walking on it. Pressure relief isn't optional—it's the baseline without which healing cannot occur.
The basics that matter
Off-loading devices
Total contact casts, removable walkers, or custom inserts that distribute pressure away from the ulcer. Non-negotiable for foot ulcers.
Proper footwear
Custom diabetic shoes with cushioning, wide toe box, and depth accommodation. Standard shoes will continue to damage healing tissue.
Activity modification
Rest periods. The wound needs metabolic resources—activity diverts them. Walking on a healing foot ulcer is like running on a broken leg.
Compression therapy (venous ulcers)
Graduated compression stockings or wraps are essential for venous ulcers. They reduce the venous pressure driving the wound.
Condition-specific tips
Diabetic foot ulcers: Neuropathy means you can't feel pain signals. You could be causing damage without knowing. Off-loading is preventive in ways that go beyond what you can feel.
Venous ulcers: Compression reduces the hydrostatic pressure that's literally forcing fluid and bacteria into the wound. It's not optional.
Test pressure relief effectiveness: Mark ulcer edges with a pen. If edges are shrinking weekly despite activity, pressure relief is working. If stable or growing, pressure relief is insufficient.
What to keep in mind.
warning
Becaplermin is FDA-Approved But Limited
Becaplermin (Regranex) is FDA-approved and proven for diabetic foot ulcers, but not all diabetic ulcers respond, especially if pressure relief and glucose control are inadequate. Other peptides show promise but lack FDA approval for wound healing.
error
Pressure Relief is Non-Negotiable
No peptide will heal a chronically pressure-loaded wound. You can apply every growth factor known to medicine and still fail if pressure relief is inadequate. This is the baseline.
stethoscope
Monitor for Infection Aggressively
Diabetic and venous ulcers are infection-prone. If signs of infection emerge (increased drainage, spreading redness, fever), additional antimicrobial treatment may be needed regardless of peptide therapy.
monitor_heart
This Takes Time
Even with optimal peptide therapy, most wounds take 8-12 weeks to close. Faster healing is possible but don't expect miracles in week 2.
This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before starting any new treatment.
Essential in early stages and if signs of infection emerge
Early wins to watch
trending_upWound stops advancing
trending_upInfection risk decreases
trending_upGranulation tissue improves
trending_upWound bed color improves
trending_upDrainage character changes
trending_upEpithelialization visible at margins
Support stack
Vitamin C (500-1000 mg daily)
Zinc (15-30 mg daily)
Arginine (3-5g daily)
Glutamine (5-10g daily)
Omega-3s (1-3g daily)
Protein powder (20-40g daily)
Vitamin A (5000-10000 IU daily)
Lifestyle priorities
1Pressure relief - absolutely critical
2Daily wound care protocol
3Glycemic control (HbA1c <7%)
4High protein nutrition
5Compression (for venous ulcers)
6Weekly wound measurement and monitoring
7Infection prevention
Chronic wounds have destroyed the quality of life for millions of people with diabetes and venous disease. Becaplermin is FDA-proven to work—and now, additional peptides offer synergistic mechanisms to accelerate healing even further. The key is aggressive pressure relief, pristine wound care, and optimized nutrition working alongside peptide therapy.
15% of diabetics develop foot ulcers. Many progress to amputation. You have evidence-based options now. Take them seriously—pressure relief especially—and track progress weekly. The outcome data shows that integrated peptide therapy + proper wound care beats standard care significantly.
0.01% topical gel applicationBecaplermin (Regranex) · typical range in this guide